Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kanwal Raghav

Showing results (31-40 of 102) with videos related to

Pageof 11
Sort By:
Journal of Gastrointestinal Oncology|May 13, 2022
Clinical and pathologic features correlated with rare favorable survival in patients with <i>BRAF</i> mutated colorectal cancerVan Morris, Bryan Kee, Michael Overman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2019
Plasma HER2 (<i>ERBB2</i>) Copy Number Predicts Response to HER2-targeted Therapy in Metastatic Colorectal CancerGiulia Siravegna, Andrea Sartore-Bianchi, Rebecca J Nagy, et al.
JAMA Oncology|August 16, 2019
Disparity of Race Reporting and Representation in Clinical Trials Leading to Cancer Drug Approvals From 2008 to 2018Jonathan M Loree, Seerat Anand, Arvind Dasari, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2018
Advances in HER2-Targeted Therapy: Novel Agents and Opportunities Beyond Breast and Gastric CancerFunda Meric-Bernstam, Amber M Johnson, Ecaterina E Ileana Dumbrava, et al.
Cancer|November 19, 2016
Bevacizumab combined with capecitabine and oxaliplatin in patients with advanced adenocarcinoma of the small bowel or ampulla of vater: A single-center, open-label, phase 2 studyPat Gulhati, Kanwal Raghav, Rachna T Shroff, et al.
BMC Cancer|May 17, 2017
Retrospective study of nonmucinous appendiceal adenocarcinomas: role of systemic chemotherapy and cytoreductive surgeryMarc Uemura, Wei Qiao, Keith Fournier, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 30, 2026
Real-World Biomarker-Associated Therapy in Metastatic Carcinoma of Unknown Primary: Prevalence, Impact, and OutcomesDipesh Uprety, Kieran Sweeney, Lubina Arjyal, et al.
ESMO Open|November 14, 2020
Natural history and prognostic factors for localised small bowel adenocarcinomaAndreina Colina, Hyunsoo Hwang, Huamin Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 21, 2022
Phase II Study of Ramucirumab in Advanced Biliary Tract Cancer Previously Treated By Gemcitabine-Based ChemotherapySunyoung Lee, Rachna T Shroff, Shalini Makawita, et al.
Journal of Gastrointestinal Oncology|November 18, 2021
Outcomes of patients with metastatic pancreatic cancer who progress on first restaging imagingJane E Rogers, Jonathan D Mizrahi, Graciela M Nogueras Gonzalez, et al.
Pageof 11

Showing results (31-40 of 102) with videos related to

Sort By:
Pageof 11
Journal of Gastrointestinal Oncology|May 13, 2022
Clinical and pathologic features correlated with rare favorable survival in patients with <i>BRAF</i> mutated colorectal cancerVan Morris, Bryan Kee, Michael Overman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2019
Plasma HER2 (<i>ERBB2</i>) Copy Number Predicts Response to HER2-targeted Therapy in Metastatic Colorectal CancerGiulia Siravegna, Andrea Sartore-Bianchi, Rebecca J Nagy, et al.
JAMA Oncology|August 16, 2019
Disparity of Race Reporting and Representation in Clinical Trials Leading to Cancer Drug Approvals From 2008 to 2018Jonathan M Loree, Seerat Anand, Arvind Dasari, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2018
Advances in HER2-Targeted Therapy: Novel Agents and Opportunities Beyond Breast and Gastric CancerFunda Meric-Bernstam, Amber M Johnson, Ecaterina E Ileana Dumbrava, et al.
Cancer|November 19, 2016
Bevacizumab combined with capecitabine and oxaliplatin in patients with advanced adenocarcinoma of the small bowel or ampulla of vater: A single-center, open-label, phase 2 studyPat Gulhati, Kanwal Raghav, Rachna T Shroff, et al.
BMC Cancer|May 17, 2017
Retrospective study of nonmucinous appendiceal adenocarcinomas: role of systemic chemotherapy and cytoreductive surgeryMarc Uemura, Wei Qiao, Keith Fournier, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 30, 2026
Real-World Biomarker-Associated Therapy in Metastatic Carcinoma of Unknown Primary: Prevalence, Impact, and OutcomesDipesh Uprety, Kieran Sweeney, Lubina Arjyal, et al.
ESMO Open|November 14, 2020
Natural history and prognostic factors for localised small bowel adenocarcinomaAndreina Colina, Hyunsoo Hwang, Huamin Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 21, 2022
Phase II Study of Ramucirumab in Advanced Biliary Tract Cancer Previously Treated By Gemcitabine-Based ChemotherapySunyoung Lee, Rachna T Shroff, Shalini Makawita, et al.
Journal of Gastrointestinal Oncology|November 18, 2021
Outcomes of patients with metastatic pancreatic cancer who progress on first restaging imagingJane E Rogers, Jonathan D Mizrahi, Graciela M Nogueras Gonzalez, et al.
Pageof 11